Jean-Michel Chardigny

Jean-Michel Chardigny

Auto-generated profile, based on publicly available information

Jean-Michel Chardigny

Laboratoire de Nutrition Humaine

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in Progress in Lipid Research
Verified
Journal Article
Closed access
MMM.C. Michalski
M.C. Michalski
CGC. Genot
C. Genot
CGC. Gayet
C. Gayet
CLC. Lopez
C. Lopez
FFF. Fine
F. Fine
KRK. Raynal-Ljutovac
K. Raynal-Ljutovac

1 July 2011 in Advances in Nutrition
Verified
Journal Article
Closed access
SGSarah K. Gebauer
Sarah K. Gebauer
JCJean-Michel Chardigny
Jean-Michel Chardigny
Marianne Uhre JakobsenMarianne Uhre Jakobsen
Marianne Uhre Jakobsen
BLBenoît Lamarche
Benoît Lamarche
ALAdam L. Lock
Adam L. Lock
DBDavid Baer
David Baer
There are 2 predominant sources of dietary trans fatty acids (TFA) in the food supply, those formed during the industrial partial hydrogenation of vegetable oils (iTFA) and those formed by biohydrogenation in ruminants (rTFA), including vaccenic acid (VA) and the naturally occurring isomer of conjugated linoleic acid, cis-9, trans-11 CLA (c9,t11-CLA). The objective of this review is to evaluate the evidence base from epidemiological and clinical studies to determine whether intake of rTFA isomers, specifically VA and c9,t11-CLA, differentially affects risk of cardiovascular disease (CVD) and cancer compared with iTFA. In addition, animal and cell culture studies are reviewed to explore potential pro- and antiatherogenic mechanisms of VA and c9,t11-CLA. Some epidemiological studies suggest that a positive association with coronary heart disease risk exists between only iTFA isomers and not rTFA isomers. Small clinical studies have been conducted to establish cause-and-effect relationships between these different sources of TFA and biomarkers or risk factors of CVD with inconclusive results. The lack of detection of treatment effects reported in some studies may be due to insufficient statistical power. Many studies have used doses of rTFA that are not realistically attainable via diet; thus, further clinical studies are warranted. Associations between iTFA intake and cancer have been inconsistent, and associations between rTFA intake and cancer have not been well studied. Clinical studies have not been conducted investigating the cause-and-effect relationship between iTFA and rTFA intake and risk for cancers. Further research is needed to determine the health effects of VA and c9,t11-CLA in humans.

19 August 2014 in Aging Cell
Verified
Journal Article
Open access
PDF file
NTnicolas tardif
nicolas tardif
JSJérôme Salles
Jérôme Salles
CGChristelle Guillet
Christelle Guillet
JTJoan Tordjman
Joan Tordjman
SRSophie Reggio
Sophie Reggio
Stephane WalrandStephane Walrand
Stephane Walrand
Summary: Obesity and aging are characterized by decreased insulin sensitivity (IS) and muscle protein synthesis. Intramuscular ceramide accumulation has been implicated in insulin resistance during obesity. We aimed to measure IS, muscle ceramide level, protein synthesis, and activation of intracellular signaling pathways involved in translation initiation in male Wistar young (YR, 6‐month) and old (OR, 25‐month) rats receiving a low‐ (LFD) or a high‐fat diet (HFD) for 10 weeks. A corresponding cellular approach using C2C12 myotubes treated with palmitate to induce intracellular ceramide deposition was taken. A decreased ability of adipose tissue to store lipids together with a reduced adipocyte diameter and a development of fibrosis were observed in OR after the HFD. Consequently, OR fed the HFD were insulin resistant, showed a strong increase in intramuscular ceramide level and a decrease in muscle protein synthesis associated with increased eIF2α phosphorylation. The accumulation of intramuscular lipids placed a lipid burden on mitochondria and created a disconnect between metabolic and regulating pathways in skeletal muscles of OR. In C2C12 cells, palmitate‐induced ceramide accumulation was associated with a decreased protein synthesis together with upregulated eIF2α phosphorylation. In conclusion, a reduced ability to expand adipose tissues was found in OR, reflecting a lower lipid buffering capacity. Muscle mitochondrial activity was affected in OR conferring a reduced ability to oxidize fatty acids entering the muscle cell. Hence, OR were more prone to ectopic muscle lipid accumulation than YR, leading to decreased muscle protein anabolism. This metabolic change is a potential therapeutic target to counter sarcopenic obesity.

1 March 2008 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
JCJean-Michel Chardigny
Jean-Michel Chardigny
FDFrédéric Destaillats
Frédéric Destaillats
CMCorinne Malpuech-Brugère
Corinne Malpuech-Brugère
JMJulie Moulin
Julie Moulin
DBDale E Bauman
Dale E Bauman
JSJean-Louis Sébédio
Jean-Louis Sébédio
Background: The consumption of monounsaturated trans fatty acids (TFAs) increases the risk of cardiovascular disease (CVD). Putative differences between the effects of TFAs from industrially produced and natural sources on CVD risk markers were not previously investigated in healthy subjects. Objective: We aimed to compare the effects of TFAs from industrially produced and natural sources on HDL and LDL cholesterol, lipoprotein particle size and distribution, apolipoproteins, and other lipids in healthy subjects. Design: In a randomized, double-blind, controlled, crossover design, 46 healthy subjects (22 men and 24 women) consumed food items containing TFAs (11–12 g/d, representing ≈5% of daily energy) from the 2 sources. Results: Forty subjects (19 men and 21 women) completed the study. Compared with TFAs from industrially produced sources, TFAs from natural sources significantly (P = 0.012) increased HDL cholesterol in women but not in men. Significant (P = 0.001) increases in LDL-cholesterol concentrations were observed in women, but not in men, after the consumption of TFAs from natural sources. Apolipoprotein (apo)B and apoA1 concentrations confirmed the changes observed in LDL and HDL cholesterol. Analysis of lipoprotein subclass showed that only large HDL and LDL concentrations were modified by TFAs from natural sources but not by those from industrially produced sources. Conclusions: This study shows that TFAs from industrially produced and from natural sources have different effects on CVD risk factors in women. The HDL cholesterol–lowering property of TFAs seems to be specific to industrial sources. However, it is difficult in the present study to draw a conclusion about the effect of TFAs from either source on absolute CVD risk in these normolipidemic subjects. The mechanism underlying the observed sex- and isomer-specific effects warrants further investigation.

1 October 2010 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
AHAktham Hassan
Aktham Hassan
AIAyman Ibrahim
Ayman Ibrahim
KMKhaly Mbodji
Khaly Mbodji
MCMoise Coëffier
Moise Coëffier
FZFrédéric Ziegler
Frédéric Ziegler
RMRachel Marion-Letellier
Rachel Marion-Letellier
We have previously shown that α-linolenic acid (ALA), a (n-3) PUFA exerts in vitro antiinflammatory effects in the intestine. In this study, we aimed

1 March 1997 in Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
Verified
Journal Article
Closed access
JSJ.L Sébédio
J.L Sébédio
PJP Juanéda
P Juanéda
GDG Dobson
G Dobson
IRI Ramilison
I Ramilison
JMJ.C Martin
J.C Martin
WCW.W Christie
W.W Christie